• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form EFFECT filed by Atlantic International Corp.

    1/27/25 12:15:03 AM ET
    $ATLN
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $ATLN alert in real time by email
    Notice of Effectiveness
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    Notice of Effectiveness
    Effectiveness Date: January 24, 2025 4:00 P.M.
    Form: S-4
    CIK: 0001605888
    Company Name: ATLANTIC INTERNATIONAL CORP.
    File Number: 333-284049
    Get the next $ATLN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ATLN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ATLN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

      Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

      3/28/25 7:30:00 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Atlantic International Corp. Secures Major Contract Renewal with Premier North American Baking Company

      ENGLEWOOD CLIFFS, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced that its subsidiary Lyneer Staffing Solutions ("Lyneer") has secured a significant contract renewal with a premier North American baking company in Northern California. The renewed partnership includes an expansion to additional locations, positioning Lyneer to capture approximately $10 million in spending. This expanded relationship underscores Lyneer's proven track record of delivering high-quality workforce solutions tailored to the specialized needs of the food producti

      3/6/25 12:00:00 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Atlantic International Corp. Enters Up to $10 Million Workforce Agreement with Leading Industrial Distributor

      ENGLEWOOD CLIFFS, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced that its subsidiary Lyneer Staffing Solutions ("Lyneer") has entered into a strategic workforce agreement with a major North American distributor serving the aerospace, defense, automotive, and medical sectors. The agreement, which is expected to generate up to $5 million in contract business and up to $5 million in direct hire spending, enables Lyneer to provide comprehensive staffing solutions across more than 20 locations throughout the continental United States. "We see

      2/10/25 7:00:00 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Financials

    Live finance-specific insights

    See more
    • Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

      Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under "ATLN" Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) -- Atlantic International Corp. ("Atlantic" or the "Company") (NASDAQ:ATLN), a leading provider of strategic staffing, outsourced services and workforce solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights: Q4 2024 Revenue: Revenue for the fourth quarter was $129.5 million, representing an 11.5% increase from $116.

      3/28/25 7:30:00 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 58% to 1,578,865 units (SEC Form 4)

      4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      1/10/25 6:09:49 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 29% to 2,581,408 units (SEC Form 4)

      4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      1/10/25 6:08:49 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 77% to 6,621,025 units (SEC Form 4)

      4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      1/6/25 2:46:30 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • General Counsel Tenore Michael bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 58% to 1,578,865 units (SEC Form 4)

      4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      1/10/25 6:09:49 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Chief Financial Officer Broderick Christopher bought $58 worth of shares (577,171 units at $0.00), increasing direct ownership by 29% to 2,581,408 units (SEC Form 4)

      4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      1/10/25 6:08:49 AM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Chief Executive Officer Jagid Jeffrey M bought $289 worth of shares (2,885,856 units at $0.00), increasing direct ownership by 77% to 6,621,025 units (SEC Form 4)

      4 - ATLANTIC INTERNATIONAL CORP. (0001605888) (Issuer)

      1/6/25 2:46:30 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials

    $ATLN
    SEC Filings

    See more
    • Atlantic International Corp. filed SEC Form 8-K: Leadership Update, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      5/5/25 5:30:06 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • SEC Form 10-K filed by Atlantic International Corp.

      10-K - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      3/27/25 8:45:09 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials
    • Atlantic International Corp. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - ATLANTIC INTERNATIONAL CORP. (0001605888) (Filer)

      2/28/25 4:09:39 PM ET
      $ATLN
      Biotechnology: Laboratory Analytical Instruments
      Industrials